ANDA 40721, held by Impax Labs. Bethanechol Chloride.
As of Nov 15, 2026, ANDA 40721 (Bethanechol Chloride), held by Impax Labs, was first approved by FDA on Nov 1, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 1, 2006 | Original application | Approved | None posted |
| Bethanechol Chloride5MG · tablet;oral | Bethanechol Chloride | Discontinued |
| Bethanechol Chloride10MG · tablet;oral | Bethanechol Chloride | Discontinued |
| Bethanechol Chloride25MG · tablet;oral | Bethanechol Chloride | Discontinued |
| Bethanechol Chloride50MG · tablet;oral | Bethanechol Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
